Biotech RadarJobs updated

COMPANY

NeuroEM Therapeutics, Inc.

HQ: Tampa, FL source · neuroem.com ↗

Past trials only

Also known as NeuroEM Therapeutics · 4 sources

Keywords: neurology Alzheimer Disease Late Onset Alzheimer Disease Alzheimer's Disease Fronto-temporal Dementia Parkinson Disease Cortico Basal Degeneration Posterior Cortical Atrophy Neurological Diseases or Conditions MemorEM MemorEM 1000

Location: Tampa, FL · source · Oct 15, 2026

Profile checked Oct 10, 2026

4Trials (company is sponsor)

Timeline

  1. Trial start Not phased (device or behavioral study): Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases source ↗
  2. Trial start Phase 1/Phase 2: Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease source ↗
  3. Trial start Not phased (device or behavioral study): Transcranial Electromagnetic Treatment Against Alzheimer's Disease source ↗
  4. Trial start Not phased (device or behavioral study): Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT07049341Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological DiseasesNot phased (device or behavioral study)Enrolling by invitationJul 31, 20252028-06 (estimated)
NCT03927040Transcranial Electromagnetic Treatment Against Alzheimer's DiseaseNot phased (device or behavioral study)CompletedApr 15, 2019Oct 5, 2020 (actual)
NCT04271163Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's DiseasePhase 1/Phase 2Unknown status (ClinicalTrials.gov)Feb 10, 2020Feb 28, 2021 (estimated)
NCT02958930Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's DiseaseNot phased (device or behavioral study)CompletedOct 1, 2017Jan 4, 2019 (actual)
Feedback